Seven, I agree that Q3 results were very good and that the growing cash balance is a good thing which should allow for some very opportunistic acquisitions in the near future. The main negative for now is the pending health care reform. Not being a speed reader I do not know what the House version passed yesterday would do to profits and growth if it became law, but what I've read about it worries me. My guess is that trading in the affected stocks will tell us this week. The attention now turns to the Senate which is likely to be more business friendly. The health care reform uncertainty is likely creating a buying opportunity in the space but it sure is hard to assess the potential risks at this point.